Applied Materials Is the Backbone of the AI Chip Boom, and It's Still on Sale
BUY - AMAT
Applied Materials Is the Backbone of the AI Chip Boom, and It's Still on Sale
Signal: BUY | Score: 63.97/100
Applied Materials is sitting 30% off its 52-week high while the company just posted record revenue and raised guidance. That's not a broken story, that's a gift. With AI infrastructure spending accelerating and AMAT's equipment inside virtually every cutting-edge chip fab on the planet, this pullback looks like one of the cleaner setups in the semiconductor space right now.
The Setup
AMAT is trading at $514 after peaking at $739 earlier this year. The RSI sits at 63.5, healthy momentum without being overbought. The stock is showing a solid trend continuation off its 52-week low of $203, more than doubling from that floor. Momentum score comes in at 71, the strongest component of the composite reading, suggesting buyers are quietly building positions here. The technical score of 60 points to a stock that has stabilized and is beginning to reassert itself, not one that's broken.
The Catalyst
Three things are happening at once. First, AMAT just reported record Q3 revenue of $9.12 billion, up 25% year over year, with non-GAAP EPS of $3.50 beating consensus and management raising Q4 guidance on top of that. Second, on September 29, KIOXIA joined AMAT's $5 billion EPIC Center as an innovation partner to co-develop next-gen memory for AI workloads, including NAND and HBM technology. That agreement expands AMAT's exposure to the fastest-growing corner of the memory market. Third, a planned $5 billion India investment over the next decade signals AMAT is building serious long-term infrastructure that diversifies its manufacturing footprint beyond China risk. The equipment segment is projected to grow more than 30% in calendar 2026. That number says everything.
Bull Case
- Analyst consensus target sits at $638, representing roughly 24% upside from current levels with a "strong buy" consensus rating
- Forward PE of 27.8 and a PEG ratio of just 1.02 make this a growth stock that's pricing in almost none of the AI capex cycle tailwinds
- Earnings growth is running at 42.7% year over year with 30% profit margins, this is a high-quality compounder at a discounted entry point
Bear Case
- Morgan Stanley cut its price target to $563 from $642 while holding an Equal Weight rating, signaling some caution on near-term upside
- A director sold 1,000 shares on September 10, and at a 1.6 beta, any broad market selloff hits AMAT harder than average
The Trade
- Entry: $514
- Target: $638 (analyst consensus)
- Stop Loss: $465 (roughly 10% downside protection)
- Risk/Reward: approximately 2.5 to 1
- Timeframe: 3 to 6 months, with Q4 earnings on November 12 as a near-term catalyst
*This is one person's analysis, not financial advice. Always do your own research.*